Completed
Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. The National Cancer Policy Forum convened a public workshop in 2011 to address promises and challenges in the development of combination investigational cancer therapies. The workshop’s purpose was to identify barriers that hinder development of combination investigational cancer therapies and offer potential solutions for greater collaboration.
Featured publication
Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary
Proceedings
·2012
Advances in biomedical research have increased our understanding of the complex nature of disease and the interaction of multiple molecular pathways involved in cancer. Combining investigational products early in their development is thought to be a promising strategy for identifying effective thera...
View details